Niente paura, la mielite trasversa e' colpa degli ufo...il business non si deve fermare
- Creatore Discussione marofib
- Data di Inizio
marofib
Forumer storico
cmq del 2 caso non ne parla nessuno....devo approfondire sta cosa
www.repubblica.it
Gli Stati Uniti non riprendono le sperimentazioni del vaccino di Oxford
Le autorità americane chiedono un supplemento di indagine per capire l'origine dei sintomi riferiti da una donna sottoposta ai test. Negli Usa sono …
@221
Forumer attivo
Ho visto questo, qua dice entrambi casi di same serious neurological disorder, mielite trasversa
www.rt.com
The first participant of the British trials – which are being conducted in conjunction with Oxford University – fell ill after receiving one dose of the experimental vaccine in July.
The female volunteer was later diagnosed with transverse myelitis, a rare inflammatory disease that affects the spinal cord, causing weakness, sensory alterations, and autonomic nervous-system dysfunction. The company’s spokeswoman later told the media the volunteer had undiagnosed multiple sclerosis, and the trials resumed.
The second female recipient of the vaccine suffered complications after the follow-up dose in September. AstraZeneca didn’t confirm her diagnosis, but a source told the New York Times it was also transverse myelitis.
Second AstraZeneca volunteer reportedly suffers rare neurological condition, but UK company says it’s not related to vaccine
Two people have fallen ill during the trials of AstraZeneca’s coronavirus vaccine in the UK, the company’s internal papers revealed, and a source said they had both suffered from the same serious neurological disorder.
The first participant of the British trials – which are being conducted in conjunction with Oxford University – fell ill after receiving one dose of the experimental vaccine in July.
The female volunteer was later diagnosed with transverse myelitis, a rare inflammatory disease that affects the spinal cord, causing weakness, sensory alterations, and autonomic nervous-system dysfunction. The company’s spokeswoman later told the media the volunteer had undiagnosed multiple sclerosis, and the trials resumed.
The second female recipient of the vaccine suffered complications after the follow-up dose in September. AstraZeneca didn’t confirm her diagnosis, but a source told the New York Times it was also transverse myelitis.
Ultima modifica: